title: Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery.
abstract: OBJECTIVE
  To compare clinical and humoral parameters before and after surgery in patients with incidental adrenocortical adenomas.
  
  
  METHODS
  Six patients with subclinical Cushing's syndrome and nine with non-functioning adenomas were investigated before and 12 Months after removal of the mass.
  
  
  METHODS
  Anthropometric (body weight, body mass index and waist to hip ratio), haemodynamic (blood pressure and heart rate), metabolic (lipids and oral glucose tolerance test (OGTT)), hormonal (cortisol, plasma renin activity, aldosterone, androgens and catecholamines) and bone metabolism (hydroxyproline, parathyroid hormone, osteocalcin and ostase) parameters were evaluated.
  
  
  RESULTS
  In the whole group, a significant decrease in body weight (69.7+/-3.5 vs 70.8+/-3.5 kg, P<0.03), in systolic (135.3+/-5.1 vs 145.6+/-4.9 mmHg, P<0.009) and diastolic (83.7+/-1.9 vs 91.0+/-3.5 mmHg, P<0.03) blood pressure and in glucose levels in response to OGTT (106.4+/-9.6 vs 127.5+/-6.5 mg/dl, P<0.05) was observed after surgery. All other parameters examined did not change significantly. This trend was also found in both groups separately. Analytical data showed a high frequency of overweight/obesity (66.6%), hypertension (66.6%) and impaired glucose profile (26.6%) in our patients, with a greater prevalence of these cardiovascular risk factors in the subclinical Cushing's syndrome group. After surgery, values normalized or improved in eight out of ten hypertensive patients and in three out of four patients with impaired glucose profile.
  
  
  CONCLUSIONS
  Solid adrenocortical incidentalomas are associated with some cardiovascular risk factors which may be corrected after removal of the mass. Therefore, surgery may be an appropriate choice in patients with subclinical Cushing's syndrome but also in those with solid non-functioning adenomas and coexistent cardiovascular risk factors.
authors.affiliation: Department of Internal Medicine, University of Pisa, Pisa, Italy. g.bernini@med.unipi.it
authors.forename: Giampaolo
authors.initials: G
authors.lastname: Bernini
authors.forename: Angelica
authors.initials: A
authors.lastname: Moretti
authors.forename: Pietro
authors.initials: P
authors.lastname: Iacconi
authors.forename: Paolo
authors.initials: P
authors.lastname: Miccoli
authors.forename: Renato
authors.initials: R
authors.lastname: Nami
authors.forename: Barbara
authors.initials: B
authors.lastname: Lucani
authors.forename: Antonio
authors.initials: A
authors.lastname: Salvetti
mesh_terms: D000236:Adenoma / Q000473:pathology / Q000503:physiopathology* / Q000601:surgery*; D000306:Adrenal Cortex Neoplasms / Q000150:complications / Q000473:pathology / Q000503:physiopathology* / Q000601:surgery*; D000328:Adult; D000368:Aged; D000886:Anthropometry; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure; D001835:Body Weight; D003480:Cushing Syndrome / Q000150:complications / Q000473:pathology / Q000503:physiopathology / Q000601:surgery; D005260:Female; D005951:Glucose Tolerance Test; D006439:Hemodynamics; D006728:Hormones / Q000097:blood*; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D011184:Postoperative Period; D016896:Treatment Outcome
chemical_list: D001786:Blood Glucose; D006728:Hormones